静脉注射重组高密度脂蛋白可改善脓毒症小鼠的存活率
本公众号每天分享一篇最新一期Anesthesia & Analgesia等SCI杂志的摘要翻译，敬请关注并提出宝贵意见
Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis
背景与目的
高密度脂蛋白具有多效性，包括抗炎、抗凋亡和脂多糖中和特性。本研究旨在评价静脉注射重组高密度脂蛋白(CSL-111)对不同脓毒症模型的影响。
方 法
将10周龄C57BL/6小鼠采用盲肠结扎穿孔或腹腔注射大肠杆菌或铜绿假单胞菌肺炎的方法建立脓毒症模型。脓毒症后2h给予CSL-111或生理盐水。主要观察指标为存活率。次要观察指标为血浆游离DNA和细胞因子浓度、组织学、细菌计数和生物分布。
结 论
CSL-111输注可提高不同脓毒症小鼠模型的存活率。它减少了血浆和器官的炎症，降低了细菌数量。这为探索高密度脂蛋白在感染性疾病中的治疗潜力提供了机会。
原始文献摘要
Tanaka S, Genève C, Zappella N, et al. Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis[J]. Anesthesiology, 2020, undefined: undefined.
Background: High-density lipoproteins exert pleiotropic effects including antiinflammatory, antiapoptotic, and lipopolysaccharide-neutralizing properties. The authors assessed the effects of reconstituted high-density lipoproteins (CSL-111) intravenous injection in different models of sepsis.
Methods: Ten-week-old C57BL/6 mice were subjected to sepsis by
cecal ligation and puncture or intraperitoneal injection of Escherichia coli or Pseudomonas aeruginosa pneumonia. CSL-111 or saline solution was administrated 2 h after the sepsis. Primary outcome was survival. Secondary outcomes were plasma cell-free DNA and cytokine concentrations, histology, bacterial count, and biodistribution.
Results: Compared with saline, CSL-111 improved survival in cecal ligation and puncture and intraperitoneal models (13 of 16 [81%] survival rate vs. 6 of 16 [38%] in the cecal ligation and puncture model; P = 0.011; 4 of 10 [40%] vs. 0 of 10 [0%] in the intraperitoneal model; P = 0.011). Cell-free DNA concentration was lower in CSL-111 relative to saline groups (68 [24 to 123] pg/ml vs. 351 [333 to 683] pg/ml; P < 0.001). Mice injected with CSL- 111 presented a decreased bacterial count at 24h after the cecal ligation and puncture model both in plasma (200 [28 to 2,302] vs. 2,500 [953 to 3,636] colony-forming unit/ml; P = 0.021) and in the liver (1,359 [360 to 1,648] vs. 1,808 [1,464 to 2,720] colony-forming unit/ml; P = 0.031). In the pneumonia model, fewer bacteria accumulated in liver and lung of the CSL-111 group. CSL-111–injected mice had also less lung inflammation versus saline mice (CD68+ to total cells ratio: saline, 0.24 [0.22 to 0.27]; CSL-111, 0.07 [0.01 to 0.09]; P < 0.01). In all models, no difference was found for cytokine concentration. 111Indium bacterial labeling underlined a potential hepatic bacterial clearance possibly promoted by high-density lipoprotein uptake.
Conclusions: CSL-111 infusion improved survival in different experimental mouse models of sepsis. It reduced inflammation in both plasma and organs and decreased bacterial count. These results emphasized the key role for high-density lipoproteins in endothelial and organ protection, but also in lipopolysaccharide/bacteria clearance. This suggests an opportunity to explore the therapeutic potential of high-density lipoproteins in septic conditions.
麻醉学文献进展分享
贵州医科大学高鸿教授课题组
翻译：何幼芹 编辑：冯玉蓉 审校：王贵龙